Protein Kinase C in Cancer Signaling and Therapy
Protein kinase C (PKC), a family of serine-threonine kinases, rocketed to the forefront of the cancer research field in the early 1980's with its identification as an effector of phorbol esters, natural products with tumor-promoting activity. Phorbol esters had long been of interest to the canc...
Clasificación: | Libro Electrónico |
---|---|
Autor Corporativo: | |
Otros Autores: | |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Totowa, NJ :
Humana Press : Imprint: Humana,
2010.
|
Edición: | 1st ed. 2010. |
Colección: | Current Cancer Research,
|
Temas: | |
Acceso en línea: | Texto Completo |
Tabla de Contenidos:
- Regulation of PKC Isozyme Function: From Genes to Biochemistry
- Protein Kinase C in Cancer Signaling and Therapy: Introduction and Historical Perspective
- Regulation of Conventional and Novel Protein Kinase C Isozymes by Phosphorylation and Lipids
- Phorbol Esters and Diacylglycerol: The PKC Activators
- Diacylglycerol Signaling: The C1 Domain, Generation of DAG, and Termination of Signals
- Regulation of PKC by Protein-Protein Interactions in Cancer
- PKC Isozymes in the Control of Cell Function
- Introduction: PKC Isozymes in the Control of Cell Function
- Regulation and Function of Protein Kinase D Signaling
- PKC and Control of the Cell Cycle
- PKC and the Control of Apoptosis
- Atypical PKCs, NF-?B, and Inflammation
- PKC Isozymes in Cancer
- Introduction: PKC and Cancer
- Protein Kinase C, p53, and DNA Damage
- PKCs as Mediators of the Hedgehog and Wnt Signaling Pathways
- PKC-PKD Interplay in Cancer
- Transgenic Mouse Models to Investigate Functional Specificity of Protein Kinase C Isoforms in the Development of Squamous Cell Carcinoma, a Nonmelanoma Human Skin Cancer
- PKC Isozymes and Skin Cancer
- PKC and Breast Cancer
- PKC and Prostate Cancer
- Protein Kinase C and Lung Cancer
- PKC Isozymes as Targets for Cancer Therapy
- PKC and Resistance to Chemotherapeutic Agents
- PKC? as a Target for Chemotherapeutic Drugs
- Atypical PKCs as Targets for Cancer Therapy.